INBX vs LKQ · rev $1.3M vs P/E 14, rev $6.88B
Inhibrx Biosciences, Inc. (INBX) versus LKQ Corporation (LKQ) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
LKQ Corporation (LKQ) is a auto parts company listed on US.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
INBX currently screens at market cap $1.28B. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
Not investment advice. Open the INBX and LKQ stock pages for the full models.
Not investment advice.